SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Cohen, N.
Right arrow Articles by Modai, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cohen, N.
Right arrow Articles by Modai, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Effects of Various Modalities of Oral Furosemide Administration in Mild or Severe Congestive Heart Failure

Natan Cohen

Department of Intenal Medicine "A"

Victor Dishi

Department of Intenal Medicine "A"

Ronit Zaidenstein

Department of Intenal Medicine "A"

Stefan Soback

Department of Nephrology Division, Assaf Harofeh Medical Center. Zerifin. Affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv

Joshua Weissgarten

Department of Kimron Veterinary Institute. Beit Dagan. Israel.

Zhan Averbukh

Department of Kimron Veterinary Institute. Beit Dagan. Israel.

Marina Gips

Department of Nephrology Division, Assaf Harofeh Medical Center. Zerifin. Affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv

Alex Blatt

Department of Intenal Medicine "A"

Silvia Berman

Department of Kimron Veterinary Institute. Beit Dagan. Israel.

David Modai

Department of Intenal Medicine "A"

Background: This study evaluated the optimal formulation (tablet vs solution) and frequency (once vs twice daily) of maintenance oral furosemide in compensated congestive heart failure (CHF).

Methods and Results: Eighteen patients with mild (group 1) and 18 with severe (group 2) CHF were studied. On 2 consecutive days each patient's individual fixed oral furosemide daily dosage was administered in tablet or solution in a crossover design. In an additional study. 14 patients with severe CHF received the daily dosage in tablet or solution form in two divided doses. Pharmacokinetic data were obtained in six randomly allocated patients of each group, during the once daily administration periods of either formulation. Twenty-four-hour urinary sodium and 12-hour volume were significantly greater in group 1 following furosemide solution versus tablets. In group 2, all parameters were comparable in response to single identical doses in tablets or solution. as well as to once versus twice daily administration of either formulation. These results coincided with a higher Cmax and a shorter tmax following solution.

Conclusions: A once-daily oral furosemide solution is more effective than the same dosage in tablet form in patients with mild, but not those with severe, CHF. In patients with severe CHF. the natriuretic and diuretic effects are similar whether oral furosemide in tablet or solution is administered in a once or twice daily schedule.

Key Words: furosemide tablets • furosemide solution • congestive heart failure

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 1, No. 4, 271-278 (1996)
DOI: 10.1177/107424849600100402


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement